Juvelook, Sculptra or Linerase: Which Collagen Stimulator Suits Which Problem?

A patient comes in having been quoted for three different injectables at three different clinics, all described in almost identical language. Each was called a collagen stimulator. Each was presented as a treatment for improving collagen or skin structure. Each was priced differently. Nobody explained why there were three, or which one matched what was actually wrong with her face.

They are not interchangeable, and the marketing language obscures the one thing that matters: they are built from different molecules, they are used at different depths, and they answer different questions. One is used primarily for regional volume restoration. One improves skin quality and fine texture with a modest volumising effect. One supplies collagen directly as a dermal scaffold rather than relying on the same type of biostimulatory response. Choosing between them by price or by which one a clinic promotes is how patients end up with a technically successful treatment that did not fix their concern.

This article sets out the diagnostic question that comes first, what each of the three actually contains, how to match them to a specific problem, how they differ from a filler, and what the timelines and costs look like in Singapore. If you have already decided on poly-L-lactic acid specifically and want the single-treatment detail, our guide to poly-L-lactic acid treatment for facial volume loss covers the process, aftercare and side effects in depth.

First: are you hollow, or are you loose?

This question decides whether a collagen stimulator is the right category at all, and it is worth answering before comparing products.

Volume loss. Fat pads have reduced or shifted, and underlying bone has remodelled with age. The cheek that used to be full is flatter. The temples are indented. The fold from nose to mouth corner may have deepened because there is less support above it, not because the fold itself changed. This is where a volumising collagen stimulator has a role.

Laxity. The tissue has descended and the supporting structures have changed. The jawline has softened, jowls have formed, and it feels like there is more skin than there used to be. This may need lifting or tightening treatments such as Ultherapy or Thermage. Adding volume to a face where laxity is the dominant problem can make the face look heavier rather than younger.

The test takes ten seconds. Tilt your head back, look up at the ceiling, and look at your face in a hand mirror. Gravity is now working differently on the descended tissue. If your concern largely resolves in that position, laxity is likely to be a significant part of the problem. If the hollowness is still visible with the position changed, genuine volume loss is likely contributing.

Many patients over forty-five have both, and where descent is significant, the usual sequence often addresses that first and volume second. Our guide to non-surgical lifting options covers how that side of the plan is chosen.

The three molecules, and what each one is for

All three stimulate or supply collagen. That is where the similarity ends.

Poly-L-lactic acid, as in Sculptra. A synthetic polymer with a long history of medical use, suspended as microparticles and injected into the deep dermal and subcutaneous plane depending on the area being treated. It provokes a controlled tissue response: the particles interact with the surrounding tissue, fibroblast activity increases, and new collagen is laid down over weeks to months. The particles are then gradually metabolised and cleared, while the collagen response persists. Longest track record of the three, slowest onset, and a duration that can extend to around two years. Its job is regional volume restoration: mid-face flattening, temples and loss of structural support.

Poly-D,L-lactic acid microspheres suspended in hyaluronic acid, as in Juvelook. The PDLLA microspheres drive a collagen response in the same broad way, but the hyaluronic acid carrier does something the pure polymer does not: it provides an early hydration effect while the collagen response develops. The practical consequence is that the gap between treatment and visible change feels shorter. Its job is skin quality and fine texture with a modest volume effect, rather than substantial regional volume restoration. It is generally placed more superficially than poly-L-lactic acid, which is part of why it suits texture rather than structure.

Micronised heterologous type I collagen, as in Linerase. A different proposition entirely. Rather than using a synthetic polymer to provoke a collagen response, it introduces type I collagen directly into the dermis, where it also acts as a stimulus for fibroblast activity and new collagen production. Its job is dermal density and skin quality. It does not have a conventional filling effect, and a patient with a hollow cheek will not get it filled with this.

Matching the product to the problem

The useful way to hold this is by what you are complaining about rather than by product name.

“My cheeks have gone flat and my face looks drawn.” Regional volume loss. Poly-L-lactic acid is the primary answer, generally over a course of treatments, with the result judged over several months rather than after the first session.

“My skin looks crepey and dull, and the texture has changed, but my face has not really sunk.” Skin quality with fine texture change. Poly-D,L-lactic acid microspheres in a hyaluronic acid carrier suit this better, because the deeper volume-restoration product is answering a question you have not asked.

“My skin feels thin and papery.” Dermal density and skin quality. Micronised type I collagen is designed for this, and it offers a different approach from using a synthetic polymer to stimulate a collagen response.

“I want one specific hollow corrected before an event in six weeks.” None of the three. You want a filler, for reasons set out in the next section.

“I have post-acne skin that heals slowly and looks tired.” Also none of the three as a first assumption. That is a skin-quality and recovery problem that needs to be assessed on its own, and a polynucleotide may have a role. Our guide to skin boosters covers how the hydration and repair categories are chosen, and the comparison of the two polynucleotide products covers the distinction within that category.

A patient asking which collagen stimulator is best is asking a question with no answer independent of what is actually wrong with their face. That is not evasion, it is the whole point of the assessment.

Stimulator or filler: the distinction that decides your choice

A hyaluronic acid filler occupies space immediately. You see the result the same day, it can be shaped precisely, and it is reversible if the outcome is not what you wanted. It is degraded over roughly six to eighteen months.

A collagen stimulator builds or supplies tissue. With the polymer products nothing much is visible for weeks, none of them can be shaped with a filler’s precision, they are not reversible, and the polymer products hold for two years or more.

So the decision rule is straightforward. If you need a specific contour changed with precision, or changed before a fixed date, or you want the option to undo it, a filler is the appropriate tool, and our comparison of hyaluronic acid fillers and collagen biostimulators goes further into that trade-off. If you have generalised volume loss or declining skin quality across a region, no deadline, and you want durability and tissue improvement rather than precise shaping, a stimulator is the better choice.

The irreversibility deserves weight rather than a footnote. It is why the assessment, the injection plane and the operator matter more here than with a reversible product. It is not a reason to avoid the category, and it is a reason not to have it from someone who cannot explain which plane they are injecting into and why.

Timelines, and why patience is part of the treatment

The polymer products share a pattern that patients need to understand before paying.

Weeks one to two. Swelling settles, and some of the apparent early result disappears with it. With poly-L-lactic acid, much of the fullness in the first days comes from the reconstitution fluid and swelling rather than the final result. This is the stage at which anxious patients often contact the clinic.

Weeks three to six. The collagen response is developing, but the visible change may still be subtle. With the hyaluronic-acid-carried microsphere product this phase can feel less bare, because the carrier provides an earlier hydration effect while the collagen response develops.

Months two to four. The change becomes more apparent, gradually enough that patients may notice it in photographs before they see it in the mirror.

Around month six. The cumulative result is clearer and the treatment plan can be reassessed according to what has been achieved and whether anything further is needed.

Micronised type I collagen behaves differently, since collagen is being introduced directly rather than relying on a synthetic polymer alone to stimulate the response, so the timeline should not be assumed to follow the same pattern.

A typical course for the polymer products involves more than one session, with the number and interval depending on the product, treatment area and treatment goal. At the clinic, sessions may be spaced at approximately four-week intervals where appropriate. Post-treatment massage is part of the protocol for some products, including poly-L-lactic acid, and should be followed exactly where advised. Proper product preparation, injection depth, distribution and aftercare all matter in reducing the risk of palpable nodules.

Why this matters more in Singapore

Ultraviolet exposure contributes to the breakdown of dermal collagen, and Singapore experiences high to extreme UV levels throughout the year with no winter season to substantially interrupt that exposure. A treatment whose premise is building or supporting collagen is working against that background load. Photoprotection is therefore part of protecting a result you have paid for rather than adjacent advice. The clinic standard is daily tinted SPF 50, with oral sun-protection supplements such as Crystal Tomato and Heliocare used as adjuncts from the start of the treatment cycle rather than added later. They do not replace sunscreen, which remains the foundation of photoprotection, but in practice topical sunscreen is often under-applied and under-reapplied through a normal day.

The second factor is facial pattern. Facial ageing and volume loss do not present identically across ethnicities or facial anatomies. In many Southeast Asian patients, mid-face flattening and temporal hollowing can be important components of the ageing pattern, alongside changes in the nasolabial folds and lower face. That changes which areas are treated and in what proportion, and it is a reason not to apply a treatment plan designed around a different facial structure without assessing the individual face first.

What it costs in Singapore, and what drives the number

Approximate market ranges across reputable clinics run roughly S$1,200 to S$2,000 per vial for the poly-L-lactic acid product, with most patients needing two to three vials across a course, so a full course typically sits between S$2,800 and S$5,500. The microsphere and collagen-supply products are priced per session and per area and vary more widely, since the treated area and the number of sessions differ by indication.

What moves the number: the vial or session count, which is the primary driver and makes quotes incomparable when it is not stated; whether the quote is per session or per course; correct reconstitution and handling, which is not a place to economise; and who injects, since the plane determines both result and complication profile with an irreversible product.

Pricing well below the market range warrants the same three questions as any injectable: how many vials or sessions, injected by whom, and which product exactly. At Dr Cindy’s Medical Aesthetics these treatments are doctor-performed, and the total cost of the course is set out at consultation rather than accumulating session by session.

Realistic expectations and clinical limits

Improvement is real and gradual. Patients describe looking less drawn and less tired rather than looking different, which for most is the intended outcome.

The limits, stated plainly. None of the three is primarily a lifting treatment, and a patient whose dominant problem is descent will be disappointed if that is what they are expecting from them. None corrects a deep static line on its own. The polymer products are not readily reversible. None can be shaped with a filler’s precision. And with the polymer products, the meaningful result develops gradually over weeks to months, which is one reason patients can conclude too early that the treatment has failed.

One point patients sometimes take the wrong way round. Because the polymer products are slow, some ask whether they could have a filler instead and skip the wait. For a defined contour with a deadline, yes. For generalised regional volume loss where the goal is gradual, durable tissue improvement, a stimulator is doing a different job from a filler, and substituting one for the other means accepting a different type and distribution of result. They are not simply two routes to the same place, and choosing between them by speed alone misses the reason for choosing one over the other.

What the consultation involves

Assessment should establish whether volume loss, laxity or skin quality is dominant, using clinical examination and the reversed-gravity check as a simple visual clue, before any product is named. It should identify which specific areas are affected and in what proportion, since that helps determine vial or session count and distribution. It should cover medical history including autoimmune conditions, active infection at the site, prior injectable treatments in the area and any history of nodule formation, all of which may bear on treatment choice and suitability.

You should leave knowing which problem is actually driving your concern, which of the three products matches it and why the other two do not, whether a filler would serve you better, how many sessions or vials are proposed and over what interval, the total cost of the course, the massage protocol where it applies, and the timeline over which the result should realistically be judged.

Frequently asked questions

What is the difference between Juvelook and Sculptra?

Sculptra is poly-L-lactic acid, generally injected deeper, and its job is regional volume restoration with a slower onset and longer duration. Juvelook is poly-D,L-lactic acid microspheres suspended in hyaluronic acid, generally placed more superficially, and the carrier gives an earlier hydration effect while the collagen response develops. Juvelook suits skin quality and fine texture with modest volume; Sculptra suits more substantial regional volume loss.

What does Linerase do?

It supplies micronised type I collagen directly into the dermis, where it also supports fibroblast activity and new collagen production. It is used where the goal is dermal density and skin quality rather than volume restoration. Its mechanism is different from the synthetic polymer products, so its timeline should not be assumed to follow the same pattern.

Which collagen stimulator lasts longest?

Poly-L-lactic acid has the longest established duration of the three, with results reported for around two years in some patients. The other two are generally maintained on shorter treatment cycles. Longevity varies between patients, and ongoing ultraviolet exposure continues to contribute to collagen breakdown, which makes photoprotection particularly relevant in this climate.

How long before I see results?

For the polymer products, the meaningful change develops gradually over weeks to months, with the collagen response continuing to build after the initial treatment. The hyaluronic-acid-carried product can feel less bare early on because the carrier provides an earlier hydration effect while collagen builds. With poly-L-lactic acid, much of the fullness in the first days comes from reconstitution fluid and swelling rather than the final result.

Are collagen stimulators better than fillers?

They answer different questions and neither is better in general. A hyaluronic acid filler occupies space immediately, can be shaped precisely, can usually be dissolved with hyaluronidase and commonly lasts six to eighteen months or longer depending on the product and area. A stimulator builds or supports tissue gradually, cannot be shaped with the same precision, is not readily reversible in the polymer forms, and has a different duration depending on the product. Choose by whether you need precision and a deadline, or gradual tissue improvement and durability.

How safe are they?

Poly-L-lactic acid has a long clinical history and a well-characterised safety profile. Small firm papules or nodules are recognised complications of the polymer products, with risk influenced by factors including product preparation, injection depth, distribution and technique. Bruising and swelling can occur after injection. Treatment is avoided in active infection at the site, and relevant medical conditions, previous injectable treatments and any history of nodule formation should be discussed at consultation.

Why do I have to massage the area afterwards?

For products where massage forms part of the aftercare protocol, including poly-L-lactic acid, it is intended to help distribute the product evenly through the treated area. The exact massage instructions depend on the product and treatment protocol, so follow the instructions given for the treatment you actually received.

Can I have more than one of them?

Sometimes, and in a plan rather than necessarily in a single session. A patient with both regional volume loss and poor dermal quality has two problems, and treating them in sequence can be reasonable. Combining products in one sitting is a clinical judgement about planes and areas, not a rule.

Can I combine them with lifting treatments?

Yes, and for many patients that combination can form part of the plan because volume loss and descent often coexist. Where descent is significant, it may make sense to address that before deciding how much volume restoration is needed. Timing is decided at consultation.

References

“Injectable Fillers and Collagen Stimulators for Facial Aesthetics: Products, Indications, Techniques”, Journal of Craniofacial Surgery, 2026 (https://pubmed.ncbi.nlm.nih.gov/42479576/)

“The Management of Poly-L-Lactic Acid (PLLA) Nodules: A Scoping Review and Evidence-Mapped Clinical Guidance”, Cureus, 2026 (https://pubmed.ncbi.nlm.nih.gov/42438624/)

Vleggaar D, “Facial volumetric correction with injectable poly-L-lactic acid”, Dermatologic Surgery, 2005 (https://pubmed.ncbi.nlm.nih.gov/16416596/)

National Environment Agency Singapore, UV index measurement and health advisory, 2026 (https://www.nea.gov.sg/weather/ultraviolet-index)

At Dr Cindy’s Medical Aesthetics the choice between these three is made after establishing whether volume loss, laxity or dermal quality is driving your concern, because all three are described in similar language and only one of them is likely to answer your actual question.